Physician

Andrew William Swartz, M.D.

According to 2025 Medicare claims, Andrew Swartz, M.D. (NPI: 1326530254) practices medical oncology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Butler, PA. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY ASSOCIATION INC (NPI: 1861469223; TIN: 251762980) and primary practice location at 16066-5122.

Swartz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 113 traditional Medicare patients, billed 288 HCPCS/CPT codes, and received $17,510 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 182 prescription claims across 64 beneficiaries totaling $410,433 in drug costs, led by Revlimid (Lenalidomide). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,190 to $410,433. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.